Nevertheless, given that ACE inhibitors are also shown to prevent the development of diabetic nephropathy, further investigation will be required to elucidate if, and to what extent, the pharmacological inhibition of AT1 has an additive class effect on the inhibition of diabetic complications other than the blockade of Ang II signaling. Here, ACE is linked to diabetic kidney disease.